Cas:189956-45-4 4-[(4-Hydroxypyrimidin-2-yl)amino]benzonitrile manufacturer & supplier

Chemical Name:4-[(4-Hydroxypyrimidin-2-yl)amino]benzonitrile

CAS.NO:189956-45-4

Synonyms:4-[(4-Hydroxypyrimidin-2-yl)amino]benzonitrile;benzonitrile, 4-[(1,4-dihydro-4-oxo-2-pyrimidinyl)amino]-;4-[(4-Oxo-1,4-dihydro-2-pyrimidinyl)amino]benzonitrile;4-[(4-Hydroxy-pyrimidin-2-yl)amino]-benzonitrile;Benzonitrile, 4-[(4-hydroxy-2-pyrimidinyl)amino]-;4-[(4-Oxo-1,4-dihydropyrimidin-2-yl)amino]benzonitrile

Molecular Formula:C₁₁H₈N₄O

Molecular Weight:212.207

HS Code:2933599090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:482.3±51.0 °C at 760 mmHg

Density:1.4±0.1 g/cm3

Index of Refraction:1.677

PSA:81.83000

Exact Mass:212.069809

LogP:1.11

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-[(4-Hydroxypyrimidin-2-yl)amino]benzonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-[(4-Oxo-1,4-dihydropyrimidin-2-yl)amino]benzonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-[(4-Oxo-1,4-dihydropyrimidin-2-yl)amino]benzonitrile Use and application,4-[(4-Hydroxy-pyrimidin-2-yl)amino]-benzonitrile technical grade,usp/ep/jp grade.

Related News: The Darzalex-Rd regimen got its FDA go-ahead in transplant-ineligible patients in 2019 based on data from the same phase 3 MAIA trial showing it could pare down the risk of disease progression or death by 44% after a median follow-up of 28 months. Now, after 56.2 months of follow-up, over half of Darzalex patients were still alive without their disease worsening, a showing that’s again “unprecedented” for a front-line myeloma treatment, Tendler said. 4-[(4-Hydroxypyrimidin-2-yl)amino]benzonitrile manufacturer There are however certain APIs that are unknown and so require additional substances that work in conjunction with the API to produce the required effect. 4-[(4-Hydroxypyrimidin-2-yl)amino]benzonitrile supplier The U.K. government previously purchased more than 380 million rapid tests from Innova, to help set up programs capable of screening millions of people per day—in the run-up to offering free COVID-19 testing nationwide at least twice per week. 4-[(4-Hydroxypyrimidin-2-yl)amino]benzonitrile vendor There are however certain APIs that are unknown and so require additional substances that work in conjunction with the API to produce the required effect. 4-[(4-Hydroxypyrimidin-2-yl)amino]benzonitrile factory The Darzalex-Rd regimen got its FDA go-ahead in transplant-ineligible patients in 2019 based on data from the same phase 3 MAIA trial showing it could pare down the risk of disease progression or death by 44% after a median follow-up of 28 months. Now, after 56.2 months of follow-up, over half of Darzalex patients were still alive without their disease worsening, a showing that’s again “unprecedented” for a front-line myeloma treatment, Tendler said.